Cargando…
Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol
OBJECTIVE: Demonstrate the safety and efficacy of a standardized intravenous etomidate infusion protocol in normalizing cortisol levels in patients with severe and life-threatening hypercortisolism. METHODS: A retrospective case series of seven patients representing nine episodes of severe hypercort...
Autores principales: | Carroll, Ty B, Peppard, William J, Herrmann, David J, Javorsky, Bradley R, Wang, Tracy S, Patel, Hina, Zarnecki, Katarzyna, Findling, James W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291660/ https://www.ncbi.nlm.nih.gov/pubmed/30560224 http://dx.doi.org/10.1210/js.2018-00269 |
Ejemplares similares
-
Alcohol-induced Cushing syndrome: report of eight cases and review of the literature
por: Surani, Asif, et al.
Publicado: (2023) -
Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome
por: Kannankeril, Joshua, et al.
Publicado: (2020) -
MON-172 Comparison of a Late-night Salivary Cortisol Immunoassay and a Cortisol and Cortisone LCMS Assay in Patients with Cushing’s Disease
por: Kannankeril, Joshua, et al.
Publicado: (2020) -
Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma
por: Reza‐Albarrán, Alfredo Adolfo, et al.
Publicado: (2018) -
Pharmacological management of severe Cushing’s syndrome: the role of etomidate
por: Pence, Andrea, et al.
Publicado: (2022)